Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Chargement...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Vaccinium macrocarpon
Calculateur gratuit de posologie — doses adultes et enfants selon le poids.
La canneberge est un fruit indigène d'Amérique du Nord, largement reconnue pour son rôle dans la santé du système urinaire. Elle contient des proanthocyanidines (PAC) qui empêchent les bactéries de s'adhérer aux parois du système urinaire. La canneberge est l'une des plantes les mieux étudiées pour la prévention des infections urinaires et est recommandée par de nombreux professionnels de la santé.
Cranberry (Vaccinium macrocarpon) is the only herb with Level A evidence for urinary tract infection (UTI) prevention. Proanthocyanidins (PACs), particularly A-type dimers and trimers, prevent bacterial adhesion to uroepithelial cells. The minimum effective dose is 36mg PACs daily, which requires concentrated extracts (not juice). Evidence is strongest for recurrent UTIs in women; it's not effective for treatment of active UTIs. Cranberry also has antioxidant and anti-adhesion properties in other systems.
A-type proanthocyanidins (PACs) are the active constituents, distinct from B-type PACs in other berries. They inhibit P-fimbriae adhesion of uropathogenic E. coli (UPEC) to uroepithelial cells by binding to bacterial adhesins. This anti-adhesion effect is dose-dependent and requires minimum 36mg PACs daily. Cranberry also acidifies urine slightly and may have quorum-sensing inhibition. The effect is bacterial-specific and doesn't significantly alter vaginal or gut microbiome. Antioxidant effects come from flavonols, anthocyanins, and phenolic acids.
La canneberge est un fruit indigène d'Amérique du Nord, largement reconnue pour son rôle dans la santé du système urinaire. Elle contient des proanthocyanidines (PAC) qui empêchent les bactéries de s'adhérer aux parois du système urinaire. La canneberge est l'une des plantes les mieux étudiées pour la prévention des infections urinaires et est recommandée par de nombreux professionnels de la santé.
Cranberry (Vaccinium macrocarpon) is the only herb with Level A evidence for urinary tract infection (UTI) prevention. Proanthocyanidins (PACs), particularly A-type dimers and trimers, prevent bacterial adhesion to uroepithelial cells. The minimum effective dose is 36mg PACs daily, which requires concentrated extracts (not juice). Evidence is strongest for recurrent UTIs in women; it's not effective for treatment of active UTIs. Cranberry also has antioxidant and anti-adhesion properties in other systems.
A-type proanthocyanidins (PACs) are the active constituents, distinct from B-type PACs in other berries. They inhibit P-fimbriae adhesion of uropathogenic E. coli (UPEC) to uroepithelial cells by binding to bacterial adhesins. This anti-adhesion effect is dose-dependent and requires minimum 36mg PACs daily. Cranberry also acidifies urine slightly and may have quorum-sensing inhibition. The effect is bacterial-specific and doesn't significantly alter vaginal or gut microbiome. Antioxidant effects come from flavonols, anthocyanins, and phenolic acids.
Cranberry works primarily through proanthocyanidins (PACs), which function as anti-adhesion agents. These compounds prevent bacteria, particularly E. coli, from adhering to the walls of the urinary tract. By inhibiting bacterial adhesion, cranberry allows the body to flush out pathogens in the urine before they can colonize and cause infection. This mechanism is well-documented and supports the Grade A evidence rating for cranberry in maintaining urinary tract health.
Yes, cranberry may interact with anticoagulants like Warfarin. Cranberries contain salicylic acid, which can have mild blood-thinning effects and may increase the risk of bleeding or elevate INR levels in patients taking Warfarin. While clinical data varies, healthcare providers generally advise patients on blood thinners to monitor their INR levels closely or avoid high doses of cranberry supplements to prevent potential interactions.
The standard adult dosage for preventing urinary tract infections is 500mg of cranberry extract taken once or twice daily. Alternatively, consuming 240-300ml of unsweetened cranberry juice daily is effective. It is important to choose unsweetened products or standardized supplements to avoid excessive sugar intake, which can counteract benefits. Consistency in dosing is necessary to maintain the anti-adhesion effect in the urinary tract.
Cranberry is generally considered safe during pregnancy when consumed in food amounts or standard supplemental dosages. It is often recommended to help prevent urinary tract infections, which are common during pregnancy. However, pregnant women should avoid consuming excessive amounts of sweetened cranberry juice due to blood sugar concerns. As with any supplement, consultation with a healthcare provider is recommended before use.
Yes, high doses of cranberry may increase the risk of kidney stones in susceptible individuals. Cranberries contain moderate levels of oxalates, which can contribute to the formation of calcium oxalate stones. Patients with a history of oxalate kidney stones should exercise caution and avoid high-dose supplementation. Moderate consumption is typically safe for the general population, but those with a history of stones should consult a physician.